GG 623 GG 623 (Terazosin 5 mg)

Pill imprint GG 623 GG 623 has been identified as Terazosin hydrochloride 5 mg.

Terazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; hyperhidrosis and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Terazosin 5 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for GG 623 GG 623

Terazosin hydrochloride 5 mg GG 623 GG 623
Terazosin hydrochloride 5 mg GG 623 GG 623
Terazosin hydrochloride
Imprint:
GG 623
GG 623
Strength:
5 mg
Color:
Pink
Size:
16.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antiadrenergic agents, peripherally acting
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Sandoz Pharmaceuticals Inc.
National Drug Code (NDC):
00781-2053
Inactive Ingredients:
corn starch
crospovidone
D&C Yellow No. 10
D&C Red No. 28
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
gelatin
lactose monohydrate
magnesium stearate
microcrystalline cellulose
shellac
propylene glycol
ferrosoferric oxide
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
63739-0426 McKesson Packaging Services
00904-6128 Major Pharmaceuticals
54569-4875 A S Medication Solutions LLC (repackager)
54868-4248 Physicians Total Care Inc (repackager)
67544-0084 Prepak Systems Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)